• About
    • About Us
    • Our Team
    • Board of Directors
    • Scientific Advisors
    • Clinical Advisors
  • Technology
  • Pipeline
    • Pipeline
    • Bladder Cancer (STK-01)
  • Investors & Partners
  • News
  • Contact

News

CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial

February 11, 2019 by Sitkastaff

Bladder cancer medical concept as a urinary anatomical organ symbol with microscopic cancerous malignant cells spreading in the human body as a healthcare 3D illustration.

Vancouver, Canada – CDRD, Canada’s national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with

read more

Sitka Biopharma Announces New Investment from Global Health Sciences Fund

October 25, 2018 by Sitkastaff

Vancouver, Canada: Sitka Biopharma is pleased to announce that Quark Venture Inc. and GF Securities, through their Global Health Sciences

read more

Sitka Biopharma Announces New Board Members

August 29, 2017 by sitkaadmin

Sitka Biopharma Inc. is pleased to announce that Dr. Kristine Swiderek and Dr. Jack Geltosky have joined its Board of

read more

Quark Venture releases final tranche of funding

August 7, 2017 by Sitkastaff

Quark Venture’s early investment in Sitka Biopharma helps the Vancouver-based company advance to clinical trials. We are pleased to announce

read more

New Bladder Cancer Therapy to Start Clinical Trials

June 26, 2017 by Sitkastaff

June 26, 2017 – Vancouver, BC and London, UK: An experimental treatment for bladder cancer will move into an early

read more

Sitka Biopharma is Ready to Rocket!

March 6, 2017 by Sitkastaff

On March 3, 2017 Rocket Builders announced its 15th annual “Ready to Rocket” lists.  These lists profile British Columbia technology

read more

Quark Venture Makes Significant Seed Investment in CDRD-UBC Spin-off, Sitka Biopharma

April 13, 2016 by Sitkastaff

Vancouver, Canada – April 13, 2016: Sitka Biopharma is pleased to announce that Quark Venture has made a significant seed

read more

Exploiting the potential of nanotechnology in bladder cancer treatment

June 25, 2015 by Sitkastaff

Learn more about Sitka Biopharma’s unique approach to bladder cancer in International Innovation! Drs Helen Burt, Michael Parr, Richard Liggins and

read more

CDRD Ventures Inc. of Vancouver, Canada Launches New Spin-off, Sitka Biopharma

December 3, 2013 by sitkaadmin

Vancouver, Canada – December 3, 2013: CDRD Ventures Inc. (CVI), the commercialization vehicle of The Centre for Drug Research and

read more

OUR PARTNERS


Explore our Website

  • Home
  • About Us
    • About Us
    • Board of Directors
    • Our Team
    • Scientific Advisors
    • Clinical Advisors
  • Technology
  • Pipeline
    • Pipeline
    • Bladder Cancer (STK-01)
  • Investors & Partners
  • News
    • News
  • Contact

Follow Sitka Biopharma

Headquarters
2500 - 1075 West Georgia
Vancouver, BC, Canada
V6E 3C9

Copyright 2021 Sitka Biopharma, all rights reserved.